Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$13.90 – $19.16
99% from low
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $81.5M | $87.2M | $85.7M | $89.9M | $97.6M | $98.6M | $102.9M | $104.4M |
| Cost of revenue | $42.0M | $44.0M | $43.3M | $46.5M | $50.6M | $52.9M | $57.7M | $61.4M |
| Gross profit | $39.6M | $43.2M | $42.4M | $43.5M | $47.0M | $45.7M | $45.1M | $42.9M |
| Gross margin | 48.5% | 49.6% | 49.5% | 48.3% | 48.2% | 46.4% | 43.9% | 41.1% |
| R&D | $1.8M | $1.8M | $2.0M | $1.6M | $1.5M | $1.6M | $1.7M | $1.6M |
| Operating income | $19.7M | $22.1M | $13.7M | $17.1M | $22.0M | $14.8M | $16.5M | $11.6M |
| EBITDA | $23.8M | $26.5M | $17.6M | $22.0M | $27.7M | $24.6M | $23.9M | $18.5M |
| Net income | $21.2M | $15.3M | $8.2M | $10.2M | $12.4M | $9.4M | $10.6M | $8.3M |
| Net margin | 26.0% | 17.6% | 9.6% | 11.4% | 12.7% | 9.5% | 10.3% | 8.0% |
| EPS (diluted) | 3.31 | 3.11 | 1.75 | 1.45 | 1.75 | 1.32 | 1.53 | 1.23 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds FONR.
No tracked institution reports a position in FONR as of their last filing.
| Execution date | Ratio |
|---|---|
| 2007-04-17 | 1-for-25reverse |
No one on the platform has traded FONR yet.
| $121M |
| — |
| IFRXInflaRx N.V. | $2.28 | +18.75% | $165M | — |
| LUNGPulmonx Corporation | $1.33 | +6.40% | $56M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 15.4× earnings vs its 11.4× historical median P/E.
Fair value ≈ $14.17 · price $19.09 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$FONR accepted shareholder approval of its merger with FONAR LLC, clearing the path for a June 3 closing.
View on StockTwits ↗https://nfne.ws/296996 $FONR #DAMADIAN #FONR #HMCA #STANDUPMRI #UPRIGHTMRI #HealthCare #Technology #Earnings #QuarterlyResults #Results #NA
View on StockTwits ↗https://nfne.ws/283879 $FONR #DAMADIAN #FONR #HMCA #STANDUPMRI #UPRIGHTMRI #HealthCare #Technology #Earnings #QuarterlyResults #Results #NA
View on StockTwits ↗$FONR Former SAC Capital trader doing the buyout arbitrage trade with FONR. They have a history of doing so. https://gemini.google.com/share/8196109f3e2e
View on StockTwits ↗$FONR $KELYA Spent last night talking to our free analysts Gemini, Grok and Perplexity about KELYA. I recommend asking each the same questions to see what they provide. they do make mistakes (hallucinations, use old info that is no longer pertinent or worse old info that greatly changes the situation). anyway, this morning went back to Gemini and discussed scenarios and risk reward owning shares in each at today's prices, logic, incentives in the M&A gamesmanship FONR vote failure, bump up offer above $19/sh KELYA buying shares now around today's trading price, M&A gamesmanship https://gemini.google.com/share/3046b901460b
View on StockTwits ↗$FONR Everyone needs to vote for this as it needs a majority of common holders other than insiders and CEO states below he will not vote for competing higher offers (see below)and yes he owns more than majority of voting stock. He knows price is too low and top holders probably disagree with price. 2.5 times cash flow and 25% below book value. No deal then where? Stock even in 14's had built in deal priced in. From The CEO's 13-d filed 7/11/25 Other Matters. Although the Board may choose to seek other competing offers to acquire FONAR, please note that I, personally, as a holder of FONAR Stock, will not support or vote in favor of any alternative transaction submitted or proposed by any third party or parties.
View on StockTwits ↗$FONR FONAR Corporation (NASDAQ:FONR) combines MRI system innovation with imaging center operations, creating a business model that public markets have historically struggled to fully appreciate. https://globalmarketbulletin.com/is-fonr-stock-misunderstood-inside-fonar-corporation-fonrs-hidden-value-in-medical-imaging/
View on StockTwits ↗Market Moves to Watch! $TSLA $NEM $FONR $SOPA $APLD are shaking Wall Street. who's ready to ride the waves into 2026? check the full breakdown https://stocksrunner.com/news/2025-12-30-wall-street-ends-2025-in-decline
View on StockTwits ↗Top Gainers PT2 $MENS $ULY $ZCMD $FLYE $FONR
View on StockTwits ↗$FONR $XBI $IBB $XLV $LABU Healthcare sector. Fonar (FONR) is acquired today for $19 per share and I want to give credit where credit is due. I bought FONR thanks to Value Digger, a veteran fund manager who has an excellent value research on Seeking Alpha with many outstanding reviews: https://seekingalpha.com/author/value-digger I did not know FONR before and I bought it at $13.50 per share thanks to his BUY recommendation, so I owe him a lot.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.